Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Agilysys, Inc. (AGYS) - free report >>
Enphase Energy, Inc. (ENPH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Agilysys, Inc. (AGYS) - free report >>
Enphase Energy, Inc. (ENPH) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 29th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 29th:
Agilysys, Inc. (AGYS - Free Report) : This developer and marketer of hardware and software products and services to the hospitality industry has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.
Agilysys, Inc. Price and Consensus
Agilysys, Inc. price-consensus-chart | Agilysys, Inc. Quote
Agilysys’ shares gained 22.4% over the last one month above the S&P 500’s increase of 1.7%. The company possesses a Momentum Score of B.
Agilysys, Inc. Price
Agilysys, Inc. price | Agilysys, Inc. Quote
Aptose Biosciences Inc. (APTO - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
Aptose Biosciences, Inc. Price and Consensus
Aptose Biosciences, Inc. price-consensus-chart | Aptose Biosciences, Inc. Quote
Aptose Biosciences’ shares gained 12.7% over the last one month. The company possesses a Momentum Score of B.
Aptose Biosciences, Inc. Price
Aptose Biosciences, Inc. price | Aptose Biosciences, Inc. Quote
Enphase Energy, Inc. (ENPH - Free Report) : This marketer ofhome energy solutions for the solar photovoltaic industry has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days.
Enphase Energy, Inc. Price and Consensus
Enphase Energy, Inc. price-consensus-chart | Enphase Energy, Inc. Quote
Enphase Energy’s shares gained 27.1% over the last one month. The company possesses a Momentum Score of B.
Enphase Energy, Inc. Price
Enphase Energy, Inc. price | Enphase Energy, Inc. Quote
Veru Inc. (VERU - Free Report) : This oncology and urology biopharmaceutical company, and devices for the consumer, professional, and industrial marketscarries a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Female Health Company (The) Price and Consensus
Female Health Company (The) price-consensus-chart | Female Health Company (The) Quote
Veru’s shares gained 4.1% over the last one month. The company possesses a Momentum Score of B.
Female Health Company (The) Price
Female Health Company (The) price | Female Health Company (The) Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>